BEIJING (Reuters) – Three doctors in Shanghai and one in Hunan province have been suspended pending investigations over allegations they took kickbacks from pharmaceutical corporations, Chinese state media reported.
In an investigative report aired on Saturday, China Central Television confirmed pharmaceutical gross sales representatives paying sweeteners to doctors at six hospitals in Shanghai and Hunan.
The bribes amounted to 30 to 40 % of the gross sales worth of the medicine, in line with the report.
Anti-graft authorities in Shanghai are investigating and authorities in Hunan pledged to enhance supervision of pharmaceutical gross sales.
The National Health and Family Planning Commission has dispatched groups to research.
In June, China’s prime graft buster criticized the health ministry and meals and drug administration for issues together with bribe-taking for drug purchases.
China’s healthcare system is blighted by crowded hospitals, corruption and tensions between sufferers and employees, and the federal government has struggled to implement reforms.
(Reporting by Ryan Woo; Editing by Robin Pomeroy)